Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Covalon Technologies's Enterprise Value is $33.99 Mil.
Covalon Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $4.43 Mil. Therefore, Covalon Technologies's EV-to-OCF for today is 7.68.
The historical rank and industry rank for Covalon Technologies's EV-to-OCF or its related term are showing as below:
CVALF'
s EV-to-OCF Range Over the Past 10 Years
Min: -381.45 Med: -10.94 Max: 5321.05
Current: 7.82
During the past 13 years, the highest EV-to-OCF of Covalon Technologies was 5321.05. The lowest was -381.45. And the median was -10.94.
CVALF's EV-to-OCF is ranked worse than 50.06% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.82
vs CVALF: 7.82
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Covalon Technologies's PE Ratio (TTM) for today is calculated as:
Covalon Technologies's share price for today is $1.62.
Covalon Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.036.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Covalon Technologies EV-to-OCF Related Terms
Covalon Technologies EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Covalon Technologies's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Covalon Technologies's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Covalon Technologies EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Covalon Technologies's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Covalon Technologies's EV-to-OCF falls into.
Covalon Technologies's current Enterprise Value is $33.99 Mil.
Covalon Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Covalon Technologies (CVALF) has a EV-to-OCF of 7.68 as of Aug. 09, 2026. According to the industry distribution chart, Covalon Technologies ranks #427 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is Covalon Technologies' EV-to-OCF too high?
Covalon Technologies' current EV-to-OCF is 7.68. The Medical Devices & Instruments industry median EV-to-OCF is 7.82. Covalon Technologies' value of 7.68 is 1.8% below this industry median. Based on the distribution chart, Covalon Technologies ranks #427 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Covalon Technologies has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Covalon Technologies ranks #427 out of 853 companies for EV-to-OCF. This places Covalon Technologies in the lower half of its industry. The industry median EV-to-OCF is 7.82. Covalon Technologies' value of 7.68 is 1.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.82, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Covalon Technologies's current EV-to-OCF of 7.68 is 1.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Covalon Technologies's current EV-to-OCF is 7.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Fairly Valued. The stock's GF Value™ is $1.69, compared to a current price of $1.62 — trading 4.1% below its estimated fair value. The current EV-to-OCF is 7.68 and 1.8% below the Medical Devices & Instruments industry median of 7.82. Covalon Technologies' overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current EV-to-OCF is 7.68 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Covalon Technologies (CVALF) Overvalued in 2026?
Based on GuruFocus' analysis, Covalon Technologies stock appears to be undervalued.
The current stock price of $1.62 is trading 4.1% below its estimated GF Value™ of $1.69.
GuruFocus considers Covalon Technologies to be Fairly Valued.
Key valuation signals for CVALF:
EV-to-OCF: 7.68
GF Value™: $1.69 vs. price of $1.62 (4.1% below fair value)
Industry Position: 1.8% below the Medical Devices & Instruments median (#427 of 853)
No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
85GF Score
Get the complete analysis for CVALF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVALF has been successfully added to your 
